Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient-Specific Blood Pressure Estimation Using Elastography-Integrated Arterial Tonometry: Design, Development, and Experimental Evaluation in a Phantom Model.

Journal of medical devices·2026

Same author

Death-associated protein kinase 2 (DAPK2) propagates endoplasmic reticulum stress in macrophages to worsen sepsis through HSPA5-IRE1α axis.

Molecular biomedicine·2026

Same author

Integrated sludge resources hierarchical recovery: enhancing VFAs production through pilot scale liquid-state anaerobic fermentation by sludge residues-based biochar.

Bioresource technology·2026

Same author

Photoluminescent Thermal Response Regulation in Zinc Metal Halide Materials Through Sn<sup>2+</sup> Alloying-Induced Carrier Localization for Visualization-Enabled Temperature Sensor.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Too Much of a Good Thing: Dramatic Strategies, Engagement and Knowledge Acquisition in Health-Related Short Videos.

Health communication·2026

Same author

Next-Generation Short-Wave Infrared LED Phosphors Based on Chromium Doped Rare Earth Sulfides.

Advanced materials (Deerfield Beach, Fla.)·2026

Search research articles

Related Experiment Video

Updated: Aug 27, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Computational modeling of hypercoagulability in COVID-19.

Ge Zhu¹, Susree Modepalli², Mohan Anand³

¹Center for Biomedical Engineering, Brown University, Providence, USA.

Computer Methods in Biomechanics and Biomedical Engineering

|September 26, 2022

Summary

Mathematical modeling reveals key factors driving blood clot formation in COVID-19. Increased fibrinogen and decreased antithrombin significantly elevate thrombin and fibrin levels, contributing to hypercoagulability in patients.

Keywords:

COVID-19 Coagulation Mathematical Modeling Precision Medicine

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

Related Experiment Videos

Last Updated: Aug 27, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

Area of Science:

Biomedical Engineering
Computational Biology
Hematology

Background:

Coronavirus disease 2019 (COVID-19) presents a significant global health challenge, with hypercoagulability contributing to mortality.
Understanding the mechanisms of COVID-19-induced hypercoagulability is crucial for developing effective treatments.

Purpose of the Study:

To investigate the association between COVID-19-induced hypercoagulability and blood clot formation using mathematical modeling.
To identify specific coagulation factors responsible for increased clot formation in COVID-19 patients.

Main Methods:

Utilized published coagulation factor data from COVID-19 patients as input for two mathematical models of coagulation.
Simulated the changes in coagulation factor concentrations to assess their impact on thrombin and fibrin generation.

Main Results:

Simulation results indicated that elevated fibrinogen and reduced antithrombin levels are primary drivers of increased thrombin and fibrin generation, respectively.
Abnormal levels of multiple coagulation factors in COVID-19 patients were found to promote clot formation.

Conclusions:

Mathematical modeling effectively identifies key coagulation factors contributing to hypercoagulability in COVID-19.
Fibrinogen and antithrombin are critical targets for mitigating excessive blood clot formation in COVID-19 patients.